Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
47 Cards in this Set
- Front
- Back
What is angina pectoris?
|
Principle symptom of heart disease
Caused by oxygen req by heart and oxygen supplied to the heart via coronary vessels Char. by sudden, severe substernal chest pain, ceased by stopping the precipitating event - exercise, stress, eating, sex May occur at rest or while sleep |
|
About how much or the artery lumen has to be blocked before there are any si/sx experienced by the pt?
|
65-70% lumen..noninvasive test normal until plaque converts into obstructive atherosclerotic plaque
|
|
Differentiate between stable and unstable angina -
|
Stable - pain pattern and char relatively unchaged over past several months (Better prognosis)
Unstable - pain pattern freq increasing along with intensity and duration - poor prognosis (MI pending) Also, vasospastic or prinzmetal's or variant angina |
|
Some factors affecting myocardial O2 demand -
|
Ventricular wall stress
HR Contractility Preload (decreased by venodilation) Afterload (decreased by dec PVR) |
|
Some medication managements for angina -
|
Nitrates
beta blockers calcium channel blockers anti-platelet agents antihyperlipidemics |
|
Surgery options for angina -
|
PCI
CABG |
|
Different types of nitrates -
|
Abortive (acute)
Preventive (prevent chest pain in recurring angina episodes) |
|
Examples of abortive nitrates -
|
Nitroglycerin (tablets, aerosol, ointment)
|
|
Some medical uses of NTG
|
Angina pectoris (ischemic HD)
HTN crisis Uterine tone reduction Erections in ED IV form used for BP control in perioperative HTN, tx of CHF, ischemic pain and pulmonary edema assoc with MI |
|
NTG has most effect on what kind of vessels in the body
|
Veins >> Arteries
|
|
Char of NTG -
|
Prototypical nitrate
Large first pass with oral form - so only topical, sublingual or aerosol Not been shown to reduce mortality Stored in dark amber bottle to be prevented from degrading by light/moisture |
|
MOA of Nitrates -
|
Relaxes vascular smooth muscle by causing releasing of NO which act on GTP to be converted into cGMP -> ultimately relaxes SM
|
|
Tolerance with nitrates -
|
Longer acting nitrates causes lose of sulfhydryl groups which is necessary for efficacy of nitrates.
Typically appears with NTH patches and longer acting nitrates |
|
How can tolerance with nitrates be avoided?
|
Omitting the evening dose in patients who do not experience angina at night.
10-12 hr nitrate free interval is reqd to prevent tolerance |
|
What form is NO under relaxing form?
|
EDRF - responsible for resting vasodilator tone present in human resistance arterioles under basal conditions
Nitrates can cause release of NO in endothelium independent manner |
|
Hemodynamics effect of Nitrates -
|
Selective for venous rather than arteriolar SMC
Venodilation -> reduced VF -> decrease in ventricular chamber diameter -> decrease in wall tension -> decreased Cardiac work and O2 demand Coronary blood flow increases -> due to decreased LVEDP + NO mediated coronary art relaxation |
|
Some non traditional uses for Nitrates-
|
Relieves the pain in esophagus spasm and biliary or renal colic be relaxing non vascular smooth muscle
|
|
Nitrates effect on afterload -
|
Don't reduce afterload when given subling/topically/patch..
|
|
Nitrates relieve angina by -
|
Arteriolar dilatation: reducing cardiac afterload and thus myocardial work and oxygen demand (only IV form)
Peripheral venodilatation: reducing venous return, cardiac preload and thus myocardial workload Relieving coronary vasospasm redistributing myocardial blood flow to ischaemic areas of the myocardium |
|
What is benefit of using Isosorbide mononitrate and isosorbide dinitrate over regular NTG?
|
Long acting nitrates relatively resistant to hepatic catabolism
t1/2 = 1 hr |
|
Pharmacokinetics for NTG -
|
t1/2 - 10mins
Extensive first pass metabolism => so given sublingual => rapid absorption and onset Sx of angina may return after metabolization -> so given patch form for steady avail |
|
Main uses of long acting Nitrates
|
Acute relief of angina
Prophylaxis in situations that may provoke angina Long-term prophylaxis of angina |
|
Adverse effects of nitrate -
|
Hypotension in pts with decreased cardiac reserve
Not to use PDE 5 inhibitor for ED in 24 hrs of Nitrate admin Headache -> assurance that nitrate is working Tachyphylaxis -> solved by removing patch at night to have nitrate free period |
|
Main uses of Beta blockers -
|
prophylactic treatment of angina
Reduce risk of sudden death or reinfarction following MI Also in HTN, arrhythmias, essential tremor and hyperthyroidism |
|
MOA of Beta receptors -
|
β-Adrenoceptors are linked via stimulatory G-proteins to adenyl cyclase, so endogenous β-agonists (norepinephrine and epinephrine) increase cytoplasmic cAMP.
|
|
MOA of Beta blockers -
|
Decrease the HR, resulting in decreased myocardial oxygen demand and increased oxygen delivery to the heart
Decrease myocardial contractility, helping to conserve energy or decrease demand |
|
Clinical effectiveness of Beta blockers -
|
improve the survival rate of patients with recent MI
improve the survival rate and prevent stroke and CHF in patients with hypertension adjust the dose of -blockers to reduce heart rate at rest to 55 to 60 bpm increase in heart rate during exercise should not exceed 75% of the heart rate response associated with onset of ischemia |
|
What happens in people with coronary artery vasospasm who are treated with beta blockers?
|
Conversely, patients in whom coronary artery spasm is particularly important may paradoxically deteriorate if treated with β-blockers because of unopposed α-adrenoceptor-mediated coronary vasoconstriction, although this is uncommon.
DOC - nitrates |
|
Adverse effects of beta blockers -
|
Obstructive airways
Heart block Hyperglycemia (may mask hypoglycemia in diabetics) Worsen perip vascular dz or raynaud's phenomenon abrupt discontinuation -> rebound increase in freq and severity of angina Minor effect - dizziness, fatigue, mental depression, drowsiness, impotence, wheezing, dyspnea |
|
Benefit of using atenolol and metoprolol over propanolol -
|
Atenolol and/or metoprolol have largely replaced propranolol - "cardioselective" - need less frequent dosing, and the clinically useful range of doses is narrower than propranolol, making them easier to use.
|
|
Pharmacokinetics of Propanolol, Metoprolol, and atenolol -
|
Propanolol - variable presystemic metabolism CYP2D6
Atenolol - kidneys, largely unchnged Metoprolol - hepatic met |
|
Pharmacokinetics of CCB -
|
Absorbed from GI, metabolized in liver, and inactive metabolites excreted in urine
|
|
MOA of CCB -
|
inhibits the passage of calcium ions through voltage- dependent L-type calcium channels in cell membranes in the heart and vascular smooth muscle as well as some other excitable tissues.
Ca2+ channels open more slowly "slow" channels (compared to Na+ channels). In cardiac tissue Ca2+ channels contribute to the membrane current during the plateau phase of the cardiac action potential, slow initial depolarization SA and AV nodes. |
|
Dihydropridines -
|
the ones that end in -dipine
|
|
Pharmacologic effect of CCB -
|
Relaxation of coronary VSM - in pts with coronary vasospasm
Arteriolar dilation - dec Afterload Decreased myocardial contract Verapamil and dilitiazem decrease cardiac conducting system - thus prevent reflex tachycardia - used in pts with unstable coronary artery dz |
|
Which CCB has most negative inotropic capability?
least? |
Most - verapamil
Least - nicardipine |
|
passport(s)
|
пАспорт (А) m.
|
|
Benefit of using CCB over beta blockers -
|
In contrast to β-blockers, calcium channel blockers may be given safely to patients with asthma, chronic bronchitis, peripheral arterial disease or diabetes.
|
|
Who is verapamil and dilitiazem CI in?
|
Pts with heart block or bradycardia
|
|
Only CCB with constipation as s/e
|
Verapamil
|
|
S/e of CCB -
|
Flushing and headache - due to vasodilation..worst in dihydropyridines
Ankle swelling - only in dihydro increased freq of urination |
|
Drug interactions CCB -
|
Beta blockers and other negative iontropic agents
|
|
Verapamil has severe drug interaction with -
|
Digoxin - increasing its plasma conc and potentially causing toxicity -> requires dose adjustment
|
|
Beta blocker effect on
Coronary blood supply HR Arterial pressure Venous Return Myocardial contractility |
Beta blocker effect on
Coronary blood supply - none HR - increases Arterial pressure - dec Venous Return - none Myocardial contractility - dec |
|
DHP CCB effect on
Coronary blood supply HR Arterial pressure Venous Return Myocardial contractility |
DHP CCB effect on
Coronary blood supply - inc HR - increase except amlodp Arterial pressure - dec Venous Return - none Myocardial contractility - dec |
|
nonDHP CCB effect on
Coronary blood supply HR Arterial pressure Venous Return Myocardial contractility |
nonDHP CCB effect on
Coronary blood supply - inc HR - dec Arterial pressure - dec Venous Return - none Myocardial contractility - dec |
|
Nitrates long acting effect on
Coronary blood supply HR Arterial pressure Venous Return Myocardial contractility |
Nitrates long acting effect on
Coronary blood supply - inc HR - inc/none Arterial pressure - dec Venous Return - dec Myocardial contractility - none |